Risk factors for mortality in TB patients: a 10-year electronic record review in a South African province
- PMID: 28061839
- PMCID: PMC5217308
- DOI: 10.1186/s12889-016-3972-2
Risk factors for mortality in TB patients: a 10-year electronic record review in a South African province
Abstract
Background: Since 1990, reduction of tuberculosis (TB) mortality has been lower in South Africa than in other high-burden countries in Africa. This research investigated the influence of routinely captured demographic and clinical or programme variables on death in TB patients in the Free State Province.
Methods: A retrospective review of case information captured in the Electronic TB register (ETR.net) over the years 2003 to 2012 was conducted. Extracted data were subjected to descriptive and logistic regression analyses. The outcome variable was defined as all registered TB cases with 'died' as the recorded outcome. The variables associated with increased or decreased odds of dying in TB patients were established. The univariate and adjusted odds ratios (OR and AOR) together with their corresponding 95% confidence intervals (CI) were estimated, taking the clustering effect of the districts into account.
Results: Of the 190,472 TB cases included in the analysis, 30,991 (16.3%) had 'died' as the recorded treatment outcome. The proportion of TB patients that died increased from 15.1% in 2003 to 17.8% in 2009, before declining to 15.4% in 2012. The odds of dying was incrementally higher in the older age groups: 8-17 years (AOR: 2.0; CI: 1.5-2.7), 18-49 years (AOR: 5.8; CI: 4.0-8.4), 50-64 years (AOR: 7.7; CI: 4.6-12.7), and ≥65 years (AOR: 14.4; CI: 10.3-20.2). Other factors associated with increased odds of mortality included: HIV co-infection (males - AOR: 2.4; CI: 2.1-2.8; females - AOR: 1.9; CI: 1.7-2.1) or unknown HIV status (males - AOR: 2.8; CI: 2.5-3.1; females - AOR: 2.4; CI: 2.2-2.6), having a negative (AOR: 1.4; CI: 1.3-1.6) or a missing (AOR: 2.1; CI: 1.4-3.2) pre-treatment sputum smear result, and being a retreatment case (AOR: 1.3; CI: 1.2-1.4).
Conclusions: Although mortality in TB patients in the Free State has been falling since 2009, it remained high at more than 15% in 2012. Appropriately targeted treatment and care for the identified high-risk groups could be considered.
Keywords: Free State Province; Mortality; Risk factors; South Africa; Tuberculosis.
Figures
Similar articles
-
Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.Int J Infect Dis. 2017 Jan;54:95-102. doi: 10.1016/j.ijid.2016.11.407. Epub 2016 Nov 25. Int J Infect Dis. 2017. PMID: 27894985
-
Unsuccessful TB treatment outcomes with a focus on HIV co-infected cases: a cross-sectional retrospective record review in a high-burdened province of South Africa.BMC Health Serv Res. 2017 Jul 10;17(1):470. doi: 10.1186/s12913-017-2406-x. BMC Health Serv Res. 2017. PMID: 28693508 Free PMC article.
-
Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa.BMC Public Health. 2019 Jul 22;19(1):973. doi: 10.1186/s12889-019-7257-4. BMC Public Health. 2019. PMID: 31331311 Free PMC article.
-
Factors associated with TB screening among agricultural workers in Limpopo Province, South Africa.Glob Health Action. 2023 Dec 31;16(1):2162227. doi: 10.1080/16549716.2022.2162227. Glob Health Action. 2023. PMID: 36661274 Free PMC article. Review.
-
Global prevalence, treatment and outcome of tuberculosis and COVID-19 coinfection: a systematic review and meta-analysis (from November 2019 to March 2021).BMJ Open. 2022 Jun 20;12(6):e059396. doi: 10.1136/bmjopen-2021-059396. BMJ Open. 2022. PMID: 35725250 Free PMC article.
Cited by
-
Survival analysis of patients with tuberculosis in Erbil, Iraqi Kurdistan region.BMC Infect Dis. 2019 Oct 21;19(1):865. doi: 10.1186/s12879-019-4544-8. BMC Infect Dis. 2019. PMID: 31638949 Free PMC article.
-
High mortality among patients with tuberculosis accessing primary care facilities: secondary analysis from an open-label cluster-randomised trial.EClinicalMedicine. 2025 Mar 18;82:103151. doi: 10.1016/j.eclinm.2025.103151. eCollection 2025 Apr. EClinicalMedicine. 2025. PMID: 40166654 Free PMC article.
-
A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?Afr J Prim Health Care Fam Med. 2018 Nov 15;10(1):e1-e5. doi: 10.4102/phcfm.v10i1.1765. Afr J Prim Health Care Fam Med. 2018. PMID: 30456967 Free PMC article.
-
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort.Eur Respir J. 2023 Nov 29;62(5):2300925. doi: 10.1183/13993003.00925-2023. Print 2023 Nov. Eur Respir J. 2023. PMID: 37827576 Free PMC article.
-
Tuberculosis Trends in the Post-COVID-19 Era: Is It Going to be a Global Concern?Health Sci Rep. 2025 May 21;8(5):e70792. doi: 10.1002/hsr2.70792. eCollection 2025 May. Health Sci Rep. 2025. PMID: 40406648 Free PMC article.
References
-
- Korenromp EL, Bierrenbach AL, Williams BG, Dye C. The measurement and estimation of tuberculosis mortality. Int J Tuberc Lung Dis. 2009;13:283–303. - PubMed
-
- World Health Organization . Global Tuberculosis Report 2015. Geneva: WHO; 2015.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical